Skip to main content
GutCited

Medium-Chain Triglycerides (MCT Oil) Bloating and Intestinal Gas

C

Readily absorbed without bile acids. Beneficial in short bowel syndrome and pancreatic insufficiency for caloric supplementation. Evidence for GI symptom reduction is limited.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dmedium\u002Dchain\u002Dtriglycerides\u0026condition\u003Dbloating\u002Dand\u002Dgas'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

結論

Readily absorbed without bile acids. Beneficial in short bowel syndrome and pancreatic insufficiency for caloric supplementation. Evidence for GI symptom reduction is limited.

Key Study Findings

Randomized Controlled Trial n=10
Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy.
Dose: 1.1 mL/kg vs: None Outcome: feasibility, safety, and tolerability of long-term (48 weeks) … 効果: None None

対象集団: Epilepsy patients

Other 4 weeks
Complex Enterally Tube-Fed Community Patients Display Stable Tolerance, Improved Compliance and Better Achieve Energy and …
Dose: 7.5 g vs: None Outcome: None 効果: None p = 0.496

対象集団: None

Review
Dietary fat intake and functional dyspepsia.
Dose: None vs: None Outcome: None 効果: None None

対象集団: Functional dyspepsia patients (dietary fat)

Key Statistics

3

研究数

200

参加者数

Positive

C

グレード

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
5-15 mL (1-3 tablespoons) per day
malabsorptionsupport:
15-30 mL per day in divided doses
antimicrobialprotocol:
1-2 tablespoons per day (caprylic acid-rich MCT)

上限量: Not established; doses above 30 mL/day commonly cause GI distress

研究で検討された用量

用量 期間 効果 N
1.1 mL/kg -- Mixed 10
7.5 g 4 weeks Mixed --
None -- Mixed --

推奨摂取タイミング: With meals; start with small doses (1 teaspoon) and increase gradually

Safety & Side Effects

報告されている副作用

  • Diarrhea and loose stools (most common, especially when starting; titrate dose up slowly)
  • Nausea and abdominal cramping
  • Bloating
  • May raise LDL cholesterol in some individuals

既知の相互作用

  • Blood sugar-lowering medications (MCTs may affect ketone and glucose metabolism)
  • Hepatotoxic medications (MCTs are metabolized in the liver; caution in liver disease)

耐容上限摂取量: Not established; doses above 30 mL/day commonly cause GI distress

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does Medium-Chain Triglycerides (MCT Oil) help with Bloating and Intestinal Gas?
Based on 3 studies with 200 participants, there is limited but promising evidence that Medium-Chain Triglycerides (MCT Oil) may support Bloating and Intestinal Gas management. Our evidence grade is C (Some Evidence).
How much Medium-Chain Triglycerides (MCT Oil) should I take for Bloating and Intestinal Gas?
Studies have used various dosages. A commonly studied range is 5-15 mL (1-3 tablespoons) per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Medium-Chain Triglycerides (MCT Oil)?
Reported side effects may include Diarrhea and loose stools (most common, especially when starting; titrate dose up slowly), Nausea and abdominal cramping, Bloating, May raise LDL cholesterol in some individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Medium-Chain Triglycerides (MCT Oil) and Bloating and Intestinal Gas?
We rate the evidence as Grade C (Some Evidence). This rating is based on 3 peer-reviewed studies with 200 total participants. The overall direction of effect is positive.

Related Evidence

Medium-Chain Triglycerides (MCT Oil) 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。